$225,000 financing for promising epilepsy research The Epilepsy Research Foundation , a distinctive joint venture of non-profit epilepsy organizations, and the Milken Family Foundation, an exclusive philanthropic foundation, announced two new grants recognizing promising epilepsy research in clinical advancement today, totaling $225,000 in funding. The grant awards had been announced by the Epilepsy Therapy Project and the Epilepsy Base, along with the Milken Family Base, through the 7th Judith Hoyer Lecture in Epilepsy at the annual meeting of the American Epilepsy Culture in Boston, MA Health .
20/20 is currently offering the technology to sector and academic researchers under service contracts. L-IHC allows for the simultaneous detection of multiple biomarkers within a tissue section while preserving its morphology and eliminating several limitations linked to the few current multiplex histology methods. It is particularly useful for studies where multi-parametric information is essential and tissue source is limiting, a typical issue in translational and clinical analysis. To predict the efficacy of targeted cancer tumor treatments it really is usually imperative to assess entire signaling pathways therefore requiring technology like L-IHC said Michael Lebowitz, 20/20’s R&D Director.